4,602 Shares in Humana Inc. $HUM Purchased by Centaurus Financial Inc.

Centaurus Financial Inc. acquired a new stake in Humana Inc. (NYSE:HUM) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,602 shares of the insurance provider’s stock, valued at approximately $1,197,000.

Other hedge funds also recently made changes to their positions in the company. Revolve Wealth Partners LLC bought a new stake in Humana in the 4th quarter valued at $202,000. Woodline Partners LP boosted its position in Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its position in Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Creative Planning increased its holdings in shares of Humana by 20.9% in the second quarter. Creative Planning now owns 31,282 shares of the insurance provider’s stock valued at $7,648,000 after purchasing an additional 5,404 shares during the last quarter. Finally, Citizens Financial Group Inc. RI acquired a new position in shares of Humana in the second quarter valued at $336,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Evercore cut their target price on shares of Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. Wolfe Research upped their price target on shares of Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research note on Thursday, January 8th. Barclays lowered their price target on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 24th. Cantor Fitzgerald reduced their price objective on Humana from $290.00 to $201.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Thursday, January 22nd. Seven research analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $225.48.

Humana Trading Down 2.2%

HUM stock opened at $166.60 on Friday. Humana Inc. has a 52 week low of $163.60 and a 52 week high of $315.35. The company has a market capitalization of $20.00 billion, a PE ratio of 16.96, a price-to-earnings-growth ratio of 1.83 and a beta of 0.44. The company’s 50-day simple moving average is $204.29 and its 200 day simple moving average is $244.61. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business’s revenue was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the company earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Friday, March 27th. Humana’s payout ratio is 36.05%.

Insider Activity

In related news, insider Sanjay K. Shetty purchased 810 shares of Humana stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the transaction, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.20% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.